Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Short term Debt (2016 - 2025)

CV Sciences (CVSI) has disclosed Short term Debt for 6 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Short term Debt rose 86.41% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 86.41% year-over-year, with the annual reading at $1.3 million for FY2025, 86.41% up from the prior year.
  • Short term Debt hit $1.3 million in Q4 2025 for CV Sciences, up from $451000.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $1.3 million in Q4 2025 to a low of $451000.0 in Q3 2025.